1. 1. Lee DS, Green LD, Liu PP, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol 2003; 41: 1573-82.
2. 2. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004; 44: 2166-72.
3. 3. Brignole M, Occhetta E, Bongiorni MG, et al; SAFE-ICD Study Investigators. Clinical evaluation of defibrillation testing in an unselected population of 2120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol 2012; 60: 981-7.
4. 4. Ashino S, Nakai T, Sonoda K, et al. Assessment of efficacy and necessity of routine defibrillation threshold testing in patients undergoing implantable cardioverter-defibrillator (ICD) implantation. Int Heart J 2015; 56: 618-21.
5. 5. Blatt JA, Poole JE, Johnson GW, et al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008; 52: 551-6.